A New Tufts Study on oncology market access has found that U.S. cancer patients get faster access to more oncology drugs than European patients, but is more better? How does comparative effectiveness research in the U.S. and the European’s Evidence-based system fit into this? Who is getting the best care? Read more here. (Source: Ulf Staginnus, Health Economics Blog, 7/10/12).
You are here: / / Are U.S. Cancer Patients Receiving Better Care Than Europeans?